<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Microduplication syndromes
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Microduplication syndromes
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Microduplication syndromes
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Carlos A Bacino, MD, FACMG
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Helen V Firth, DM, FRCP, FMedSci
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Elizabeth TePas, MD, MS
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Dec 12, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H10088450">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Microduplications, or submicroscopic duplications, are chromosomal duplications that are too small to be detected by light microscopy using conventional cytogenetics methods. Specialized testing is needed to identify these duplications. Microduplications are typically one to three megabases (Mb) long and involve several contiguous genes. The exact size and location of a microduplication that causes a syndrome may vary, but a specific "critical region" may be consistently involved. Most of the phenotypic effects of these microduplications are due to changes in a few critical dose-sensitive genes or, in some cases, a single gene if a duplication disrupts its integrity.
        </p>
        <p>
         The phenotype of microduplication syndromes is often less clear and less well defined than for the corresponding microdeletion syndrome. In addition, some microduplication syndromes may be inherited from apparently normal parents, raising important issues regarding incomplete penetrance and ascertainment bias in these newly described clinical entities.
        </p>
        <p>
         This topic reviews microduplication syndromes of chromosomes 1 to 22. Microdeletion syndromes, congenital abnormalities of the sex chromosomes, and other congenital chromosomal abnormalities, such as trisomies, are reviewed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/16660.html" rel="external">
          "Microdeletion syndromes (chromosomes 1 to 11)"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16648.html" rel="external">
          "Microdeletion syndromes (chromosomes 12 to 22)"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16974.html" rel="external">
          "Sex chromosome abnormalities"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/452.html" rel="external">
          "Congenital cytogenetic abnormalities"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4404928">
         <span class="h1">
          OVERVIEW OF GENOMIC DISORDERS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Genomic disorders are diseases that result from the loss or gain of chromosomal/DNA material. The most common and better delineated genomic disorders are divided in two main categories: those resulting from copy number losses (deletion syndromes) and those resulting from copy number gains (duplication syndromes). (See
         <a class="medical medical_review" href="/z/d/html/16647.html" rel="external">
          "Genomic disorders: An overview"
         </a>
         .)
        </p>
        <p>
         Copy number variations (CNVs) are submicroscopic genomic differences in the number of copies of one or more sections of DNA that result in DNA gains or losses  (
         <a class="graphic graphic_figure graphicRef67644" href="/z/d/graphic/67644.html" rel="external">
          figure 1
         </a>
         ). Some CNVs are pathogenic and cause syndromic disorders with consistent phenotypic features, as are discussed here. Other CNVs are associated with disease susceptibility or resistance, and the same CNV can be associated with several diverse disorders. Still other CNVs are part of normal genetic variation and have no recognized disease association. Contiguous gene syndromes can occur when CNVs affect several adjacent genes. (See
         <a class="medical medical_review" href="/z/d/html/2900.html" rel="external">
          "Basic genetics concepts: DNA regulation and gene expression", section on 'Genetic variation'
         </a>
         .)
        </p>
        <p>
         The main mechanism that leads to disease in genomic disorders secondary to deletions and duplications is a change in the copy number of a dose-sensitive gene or genes. Other disease mechanisms include interference with imprinted genes and with regulatory elements outside genes. (See
         <a class="medical medical_review" href="/z/d/html/16647.html" rel="external">
          "Genomic disorders: An overview", section on 'Disease mechanisms'
         </a>
         .)
        </p>
        <p>
         Genomic disorders are typically detected by array comparative genomic hybridization (CGH)  (
         <a class="graphic graphic_figure graphicRef58888" href="/z/d/graphic/58888.html" rel="external">
          figure 2
         </a>
         ). Most laboratories confirm gains or losses detected on an array with an independent method, such as fluorescent in situ hybridization (FISH), multiple ligation-dependent probe amplification (MLPA), or quantitative polymerase chain reaction (Q-PCR). (See
         <a class="medical medical_review" href="/z/d/html/2893.html" rel="external">
          "Tools for genetics and genomics: Cytogenetics and molecular genetics", section on 'Array comparative genomic hybridization'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2893.html" rel="external">
          "Tools for genetics and genomics: Cytogenetics and molecular genetics", section on 'Fluorescence in situ hybridization'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H10088412">
         <span class="h1">
          1q21.1 DUPLICATION SYNDROME
         </span>
         <span class="headingEndMark">
          —
         </span>
         Recurrent duplications in this region encompassing approximately 1.35 megabases (Mb) are associated with macrocephaly and mild intellectual disabilities (speech delay, learning disabilities; MIM #612475) [
         <a href="#rid1">
          1,2
         </a>
         ]. Psychiatric conditions, such as schizophrenia in adult patients [
         <a href="#rid3">
          3
         </a>
         ], and attention deficit hyperactivity disorder (ADHD) have also been reported. Other developmental disorders, such as autism spectrum disorders, have been reported in up to 41 percent of cases [
         <a href="#rid4">
          4
         </a>
         ]. Autism is most commonly observed in patients with duplications rather than deletions of this region. Abnormalities in brain imaging, including periventricular heterotopia, dilated ventricles, reduced corpus callosum, and Chiari I malformation, were observed in many cases [
         <a href="#rid4">
          4
         </a>
         ]. Other studies have reported congenital heart disease, such as tetralogy of Fallot and pulmonary stenosis, among these patients [
         <a href="#rid3">
          3,5
         </a>
         ]. The clinical presentation of this disorder is variable due to incomplete penetrance and variable expressivity. Thus, this microduplication is also seen in asymptomatic persons.
         <em>
         </em>
         Hydrocephalus-inducing, mouse, homolog of (
         <em>
          HYDIN2
         </em>
         ) is the gene implicated in this disorder. Novel NOTCH-like genes like notch 2 N-terminal-like (
         <em>
          NOTCH2NL
         </em>
         )
         <em>
          A
         </em>
         ,
         <em>
          B
         </em>
         , and
         <em>
          C
         </em>
         located in the 1q21.1 region play a role in the rapid evolution of human neocortex growth and cortical neuron differentiation [
         <a href="#rid6">
          6
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16660.html" rel="external">
          "Microdeletion syndromes (chromosomes 1 to 11)", section on 'Distal 1q21.1 deletion syndrome'
         </a>
         .)
        </p>
        <p>
         Neurodevelopmental evaluations and brain imaging studies are recommended. Older patients should be assessed for later-onset psychiatric conditions such as schizophrenia. Cardiac echocardiography should be performed in patients with suspected congenital heart disease. Patients may benefit from physical, occupational, and speech therapies.
        </p>
        <p class="headingAnchor" id="H925541529">
         <span class="h1">
          2q31 DUPLICATION SYNDROME
         </span>
         <span class="headingEndMark">
          —
         </span>
         Duplications in this region encompassing the homeobox D (HOXD) gene cluster, as well as metaxin 2 (
         <em>
          MTX2
         </em>
         ) and even-skipped homeobox 2 (
         <em>
          EVX2
         </em>
         ), have been reported in patients with mesomelic dysplasia with shortening of the arms and legs, also known as mesomelic dysplasia Kantaputra type [
         <a href="#rid7">
          7,8
         </a>
         ].
        </p>
        <p>
         Patients with this duplication would benefit from a skeletal survey to assess for possible skeletal abnormalities.
        </p>
        <p class="headingAnchor" id="H2209292379">
         <span class="h1">
          2q23.1 DUPLICATION SYNDROME
         </span>
         <span class="headingEndMark">
          —
         </span>
         Duplications of this region vary in size, but the common link is the involvement of the methyl-CpG binding domain protein 5 (
         <em>
          MBD5
         </em>
         ) gene. Duplications in this region have been linked to intellectual disability, autism spectrum disorder, language delays, infantile hypotonia with gross motor delays, and behavioral abnormalities [
         <a href="#rid9">
          9-11
         </a>
         ].
        </p>
        <p>
         Neurodevelopmental evaluation, including testing for autism spectrum disorders, is recommended.
        </p>
        <p class="headingAnchor" id="H12818213">
         <span class="h1">
          3q29 DUPLICATION SYNDROME
         </span>
         <span class="headingEndMark">
          —
         </span>
         This recurrent duplication has variable clinical findings and is the reciprocal rearrangement of the 3q29 microdeletion. p21 protein-activated kinase 2 (
         <em>
          PAK2
         </em>
         ) and discs large, drosophila, homolog of, 1 (
         <em>
          DLG1
         </em>
         ) are the critical gene candidates. Other genes contained in the region, including 3-hydroxybutyrate dehydrogenase 1 (
         <em>
          BDH1
         </em>
         )
         <em>
          ,
         </em>
         F-box protein 45 (
         <em>
          FBXO45
         </em>
         ), and transferrin receptor (
         <em>
          TFRC
         </em>
         ), are linked to neuronal development [
         <a href="#rid12">
          12
         </a>
         ]. Clinical findings include microcephaly; macrocephaly; structural brain anomalies; distinctive facial features (low-set, simple ears; downturned corners of the mouth; long, bushy eyebrows; long eyelashes; high nasal bridge); eye abnormalities (microphthalmia, cataracts, irides colobomas); cleft palate; and renal and cardiac anomalies (MIM #611936) [
         <a href="#rid13">
          13-16
         </a>
         ]. Mild-to-moderate intellectual disabilities are common, and patients may have speech delay. However, this duplication has been seen in apparently unaffected individuals. (See
         <a class="medical medical_review" href="/z/d/html/16660.html" rel="external">
          "Microdeletion syndromes (chromosomes 1 to 11)", section on '3q29 deletion syndrome'
         </a>
         .)
        </p>
        <p>
         Brain imaging studies are recommended given the association with structural brain abnormalities. Other screening studies include renal ultrasound, echocardiogram, and funduscopic eye exam. Patients may benefit from physical, occupational, and speech therapies.
        </p>
        <p class="headingAnchor" id="H12818220">
         <span class="h1">
          5q35 MICRODUPLICATION SYNDROME
         </span>
         <span class="headingEndMark">
          —
         </span>
         5q35 is the Sotos syndrome critical region that contains the Sotos syndrome gene, also known as nuclear receptor-binding Su-var, enhancer of zeste, and trithorax domain protein 1 (
         <em>
          NSD1
         </em>
         ). This gene encodes the nuclear receptor-binding SET domain protein 1, which is part of histone methyltransferase complex. These proteins participate in chromatin integrity, and many other demethylases have been implicated in neurodevelopmental disorders [
         <a href="#rid17">
          17
         </a>
         ]. The 5q35 microduplication syndrome is basically a reverse of the Sotos syndrome (overgrowth) phenotype [
         <a href="#rid18">
          18,19
         </a>
         ]. Patients with duplications involving
         <em>
          NSD1
         </em>
         present with microcephaly, global developmental delay, short stature, growth retardation, and delayed bone age. Dysmorphic features have been reported, as well as behavioral, ocular, and mild hand anomalies [
         <a href="#rid20">
          20
         </a>
         ]. Seizures have been reported in some patients. Psychiatric phenotypes have been described in older affected persons [
         <a href="#rid17">
          17
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16660.html" rel="external">
          "Microdeletion syndromes (chromosomes 1 to 11)", section on '5q35 deletion syndrome (Sotos syndrome)'
         </a>
         .)
        </p>
        <p>
         Recommended screening studies include brain magnetic resonance imaging (MRI) and electroencephalogram (EEG). Growth should be monitored.
        </p>
        <p class="headingAnchor" id="H12818227">
         <span class="h1">
          7q11.23 DUPLICATION SYNDROME (WILLIAMS-BEUREN REGION DUPLICATION SYNDROME)
         </span>
         <span class="headingEndMark">
          —
         </span>
         Deletions in this region are associated with Williams syndrome (MIM #609757). The reciprocal recurrent 1.5 to 1.8 Mb duplication causes a different clinical phenotype characterized by hypotonia and global developmental delay, with speech delay that can range from moderate to severe. Many of these patients have been diagnosed with autism spectrum disorders [
         <a href="#rid21">
          21,22
         </a>
         ]. Other behavioral abnormalities include oppositional behaviors, anxiety, attention deficit hyperactivity disorder (ADHD), and variable levels of aggression [
         <a href="#rid23">
          23,24
         </a>
         ]. Dysmorphic features are mild and without a clear characteristic pattern. Brain abnormalities have been observed and seizures reported [
         <a href="#rid25">
          25
         </a>
         ]. Other findings were demonstrated in one clinical series, including joint hyperextensibility and tendency to fracture with minimal trauma. In addition, this study showed some improvements of reciprocal social behaviors over time [
         <a href="#rid26">
          26
         </a>
         ]. The gene(s) responsible for the phenotype are not yet known. Aortic dilatation has been reported at different ages in up to 46 percent of these patients [
         <a href="#rid27">
          27,28
         </a>
         ]. Renal and genitourinary anomalies, such as renal and gonadal agenesis, are also seen in this condition [
         <a href="#rid28">
          28
         </a>
         ].
        </p>
        <p>
         Hearing evaluations are recommended to rule out other causes of speech delay. Other screening studies include speech evaluation, brain magnetic resonance imaging (MRI), and electroencephalogram (EEG). Renal ultrasound is recommended to rule out structural genitourinary anomalies. Echocardiograms are warranted at the time of diagnosis and thereafter every two to three years to rule out dilatation that could be addressed by medical or surgical treatment. Referral to speech therapy is recommended.
        </p>
        <p class="headingAnchor" id="H12818234">
         <span class="h1">
          11p15 DUPLICATIONS IN BECKWITH-WIEDEMANN SYNDROME
         </span>
         <span class="headingEndMark">
          —
         </span>
         Beckwith-Wiedemann syndrome (BWS; MIM #130650) can be caused by microduplication of the 11p15 region originating in the paternal chromosome. The major clinical features of this syndrome are macrosomia, macroglossia, omphalocele, prominent eyes, ear creases, large kidneys, hyperplasia of pancreas, and hemihypertrophy. BWS is discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/13555.html" rel="external">
          "Beckwith-Wiedemann syndrome"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H12818241">
         <span class="h1">
          15q11-13 DUPLICATION SYNDROME
         </span>
         <span class="headingEndMark">
          —
         </span>
         Deletion of this imprinted region causes Angelman/Prader-Willi syndromes depending on the parental origin. Gains and duplications of this region are seen in persons with intellectual disability and autism (MIM #608636) [
         <a href="#rid29">
          29-31
         </a>
         ]. In most cases, the delays and autism phenotypes are associated with duplication of the maternally inherited allele [
         <a href="#rid32">
          32,33
         </a>
         ]. These patients may also present with hypotonia, global developmental delay, attention deficit hyperactivity disorder (ADHD), ataxia, and seizures. The Angelman syndrome gene, ubiquitin-protein ligase E3A (
         <em>
          UBE3A
         </em>
         ), is the gene potentially responsible for the autism. (See
         <a class="medical medical_review" href="/z/d/html/16648.html" rel="external">
          "Microdeletion syndromes (chromosomes 12 to 22)", section on '15q11-13 maternal deletion syndrome (Angelman syndrome)'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16648.html" rel="external">
          "Microdeletion syndromes (chromosomes 12 to 22)", section on '15q11-13 paternal deletion syndrome (Prader-Willi syndrome)'
         </a>
         .)
        </p>
        <p>
         Formal developmental and autism evaluations are recommended. Assessment of seizures includes an electroencephalogram (EEG). (See
         <a class="medical medical_review" href="/z/d/html/628.html" rel="external">
          "Autism spectrum disorder in children and adolescents: Evaluation and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/590.html" rel="external">
          "Autism spectrum disorder in children and adolescents: Screening tools"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/615.html" rel="external">
          "Developmental-behavioral surveillance and screening in primary care", section on 'Approach to surveillance'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H12818248">
         <span class="h1">
          15q13.3 DUPLICATION SYNDROME
         </span>
         <span class="headingEndMark">
          —
         </span>
         This 1.5 megabase (Mb) microduplication is reciprocal to the 15q13.3 deletion and extends between breakpoints BP4 and BP5. One-half of persons ascertained with this duplication have a range of neuropsychiatric disorders [
         <a href="#rid34">
          34
         </a>
         ]. Patients with these duplications may present with neuropsychiatric problems including attention deficit hyperactivity disorder (ADHD), speech delays, autism spectrum disorder, and schizophrenia [
         <a href="#rid35">
          35-37
         </a>
         ]. Seizures have also been reported [
         <a href="#rid38">
          38
         </a>
         ]. The duplication contains the alpha 7 subunit of the neuronal nicotinic acetylcholine receptor (
         <em>
          CHRNA7
         </em>
         ) gene, believed to be the main player in the behavioral abnormalities [
         <a href="#rid39">
          39
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16648.html" rel="external">
          "Microdeletion syndromes (chromosomes 12 to 22)", section on '15q13.3 deletion syndrome'
         </a>
         .)
        </p>
        <p>
         Formal neurodevelopmental evaluations are recommended, especially for those presenting with developmental delays and behavioral problems.
        </p>
        <p class="headingAnchor" id="H12818255">
         <span class="h1">
          15q24 DUPLICATION SYNDROME
         </span>
         <span class="headingEndMark">
          —
         </span>
         This is the reciprocal duplication of the 15q24 deletion (MIM #613406). The cases described share similar clinical features with the deletion syndrome, including mild intellectual disability, receding anterior hairline, broad medial eyebrows, hypertelorism, epicanthal folds, downslanting palpebral fissures, broad nasal base and high nasal bridge, full lower lip, joint laxity, and in some cases, contractures, as well as hypospadias and genital anomalies in males [
         <a href="#rid40">
          40,41
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16648.html" rel="external">
          "Microdeletion syndromes (chromosomes 12 to 22)", section on '15q24 deletion syndrome'
         </a>
         .)
        </p>
        <p>
         Formal developmental evaluations are recommended. Endocrine and urology evaluation is performed in males if needed. Patients may benefit from physical, occupational, and speech therapies.
        </p>
        <p class="headingAnchor" id="H6228459">
         <span class="h1">
          16p13.3 DUPLICATION SYNDROME
         </span>
         <span class="headingEndMark">
          —
         </span>
         This duplication involves the Rubinstein-Taybi critical region and includes the cyclic adenosine monophosphate [cAMP] response element-binding protein [CREB] binding protein (
         <em>
          CREBBP
         </em>
         ) gene. Clinical features include normal growth, mild-to-moderate developmental delay, small and proximally implanted thumbs, long fingers, and mild arthrogryposis (multiple joint contractures) with camptodactyly (flexion deformities of the proximal interphalangeal joints). Dysmorphic features include deep-set eyes, narrow palpebral fissures, wide nasal bridge, long philtrum, and thin upper lip. This duplication is occasionally associated with heart defects (atrial septal defect [ASD], tetralogy of Fallot [TOF]), submucous cleft palate anomalies, and eye anomalies (strabismus, blepharophimosis, and ptosis). The penetrance of this duplication is variable since it has been found in normal transmitting parents [
         <a href="#rid42">
          42,43
         </a>
         ].
        </p>
        <p>
         Neurodevelopmental evaluations are recommended. Other screenings should include an echocardiogram and a cardiac evaluation. Patients may benefit from physical, occupational, and speech therapies.
        </p>
        <p class="headingAnchor" id="H12818262">
         <span class="h1">
          16p13.11 DUPLICATION SYNDROME
         </span>
         <span class="headingEndMark">
          —
         </span>
         Clinical findings for this duplication that spans approximately 1.65 megabases (Mb) include behavioral abnormalities, cognitive impairment, autism, congenital heart defects, and skeletal manifestations, such as hypermobility, craniosynostosis, and polydactyly. During the perinatal period, feeding difficulties and low muscle tone are common, while learning disabilities and speech delays are more frequently reported later in childhood (&gt;80 percent of patients). This duplication is considered a risk factor for neuropsychiatric disorders [
         <a href="#rid44">
          44-46
         </a>
         ].
        </p>
        <p>
         Formal developmental evaluation is recommended for those with developmental delays and behavioral concerns.
        </p>
        <p class="headingAnchor" id="H12818269">
         <span class="h1">
          16p11.2 DUPLICATION SYNDROME
         </span>
         <span class="headingEndMark">
          —
         </span>
         This recurrent rearrangement is the reciprocal event of the deletion in 16p11.2 that spans almost 600 kb. There is significant variability in the clinical manifestations, ranging from normal in the majority of cases to developmental delay and autistic spectrum disorders [
         <a href="#rid47">
          47-51
         </a>
         ]. A number of other neurodevelopmental and behavioral disorders have been observed as well [
         <a href="#rid52">
          52
         </a>
         ]. This duplication is associated with an increased risk for seizure disorders such as infantile spasms [
         <a href="#rid53">
          53
         </a>
         ] and Rolandic epilepsy [
         <a href="#rid54">
          54
         </a>
         ]. One study describing a larger cohort of 57 patients with this duplication described neurologic findings that ranged from tremors, symmetric limb hypotonia, hyperreflexia, hyporeflexia, truncal hypotonia, and articulation disorders [
         <a href="#rid55">
          55
         </a>
         ]. Other clinical findings seen in patients with this duplication include thoracolumbar syringomyelia [
         <a href="#rid56">
          56
         </a>
         ]. Changes in copy number variations (CNVs) in this locus (ie, losses or gains) modulate cognition, including language, verbal memory, and inhibition [
         <a href="#rid57">
          57
         </a>
         ]. Patients with this copy number gain have a smaller head circumference and lower body mass index (BMI; 0.6 points lower) than controls within the family [
         <a href="#rid58">
          58
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16648.html" rel="external">
          "Microdeletion syndromes (chromosomes 12 to 22)", section on '16p11.2 deletion syndrome'
         </a>
         .)
        </p>
        <p>
         Formal developmental and autism evaluations are recommended in affected patients. Electroencephalography (EEG) evaluation is indicated in patients with clinically suspected seizures. A spin magnetic resonance image (MRI) should be considered since syringomyelia may be asymptomatic. Thorough clinical neurologic evaluations or a neurology referral are recommended.
        </p>
        <p class="headingAnchor" id="H12818276">
         <span class="h1">
          17p13.3 DUPLICATION SYNDROME
         </span>
         <span class="headingEndMark">
          —
         </span>
         While deletions in the distal short arm of chromosome 17 cause Miller-Dieker lissencephaly syndrome, duplications in this region are associated with developmental delay, central nervous system (CNS) anomalies, and autism spectrum disorder (MIM #613215) [
         <a href="#rid59">
          59
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16648.html" rel="external">
          "Microdeletion syndromes (chromosomes 12 to 22)", section on '17p13.3 deletion syndromes'
         </a>
         .)
        </p>
        <p>
         There are two duplication types: class I and class II. The critical region for class I spans 258 kb and includes six genes: exons 2 to 3 of tumor suppressor candidate 5 (
         <em>
          TUSC5
         </em>
         ), tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon isoform (
         <em>
          YWHAE
         </em>
         ), v-crk avian sarcoma virus CT10 oncogene homolog (
         <em>
          CRK
         </em>
         ),
         <em>
         </em>
         myosin IC (
         <em>
          MYO1C
         </em>
         ),
         <em>
         </em>
         sphingosine kinase 1 (SPHK1) interacting protein (
         <em>
          SKIP
         </em>
         ), and exons 1 to 4 of phosphatidylinositol transfer protein, alpha (
         <em>
          PITPNA
         </em>
         ). It appears that
         <em>
          YWHAE
         </em>
         plays the main role in the CNS anomalies and autism phenotype, while
         <em>
          CRK
         </em>
         seems to be the gene responsible for growth restriction. However, subsequent reports have indicated that the duplications of
         <em>
          CRK
         </em>
         can be associated to overgrowth [
         <a href="#rid60">
          60
         </a>
         ]. The class I duplication may include the basic helix-loop-helix family member a9 (
         <em>
          BHLHA9
         </em>
         ) gene. Duplications in this gene are linked to split-hand/foot malformation with long-bone deficiency (SHFLD) [
         <a href="#rid61">
          61
         </a>
         ], although it appears that duplications of this gene alone are not enough to cause SHFLD [
         <a href="#rid62">
          62
         </a>
         ].
        </p>
        <p>
         The class II duplication additionally includes
         <em>
         </em>
         platelet-activating factor acetylhydrolase, isoform 1B, alpha subunit; formerly
         <em>
          LIS1
         </em>
         (
         <em>
          PAFAH1B1/LIS1
         </em>
         ), the lissencephaly gene responsible for lissencephaly type I.
        </p>
        <p>
         Clinical findings for class I duplications include autistic features, behavioral problems, speech and motor delays, macrosomia, mild dysmorphic features (or none), hand and feet malformations (large hands, small distal phalanges), and overgrowth (a rare feature for a chromosomal/genomic disorder). Class II duplications show a range from normal intellect to severe intellectual disability, hypotonia that can be severe, autism, attention deficit hyperactivity disorder (ADHD), microcephaly, dysmorphic features, and severe growth restriction. There are no migration abnormalities in the brain even though
         <em>
          PAFAH1B1
         </em>
         is involved. A number of structural CNS abnormalities involving the corpus callosum, cerebellar vermis, and cranial base have been reported in this group [
         <a href="#rid62">
          62
         </a>
         ].
         <em>
          PAFAH1B1
         </em>
         overexpression appears to lead to smaller brains based upon animal studies [
         <a href="#rid63">
          63
         </a>
         ]. Other abnormalities for class II duplications include craniosynostosis, intestinal malrotation, scoliosis, cardiovascular anomalies, and other skeletal anomalies.
        </p>
        <p>
         Formal developmental and autism evaluations are recommended. A brain magnetic resonance image (MRI) is also recommended in patients with class II duplications. Patients may benefit from physical, occupational, and speech therapies.
        </p>
        <p class="headingAnchor" id="H12818283">
         <span class="h1">
          17p11.2 DUPLICATION SYNDROME (CHARCOT-MARIE-TOOTH TYPE 1A DISEASE)
         </span>
         <span class="headingEndMark">
          —
         </span>
         Recurrent 1.5 megabase (Mb) duplications in 17p11.2 involving the peripheral myelin protein 22 (
         <em>
          PMP22
         </em>
         ) gene are responsible for Charcot-Marie-Tooth type 1A (CMT1A) disease (MIM #118220).
         <em>
          PMP22
         </em>
         is a dose-sensitive gene that causes CMT1A when overexpressed and hereditary neuropathy with liability to pressure palsy (HNPP) when deleted. CMT1A is a demyelinating motor-sensory neuropathy clinically characterized by progressive distal neuromuscular weakness. These patients present with foot and ankle problems including pain, weakness, deformity, and paresthesias. Foot drop and bilateral pes cavus are common. The muscles are wasted distally and conserved proximally. CMT1A is discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/6220.html" rel="external">
          "Charcot-Marie-Tooth disease: Genetics, clinical features, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16648.html" rel="external">
          "Microdeletion syndromes (chromosomes 12 to 22)", section on '17p11.2 deletion syndrome (Hereditary neuropathy with liability to pressure palsy)'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H12818290">
         <span class="h1">
          17p11.2 DUPLICATION SYNDROME (POTOCKI-LUPSKI SYNDROME)
         </span>
         <span class="headingEndMark">
          —
         </span>
         This duplication, also known as Potocki-Lupski syndrome (PLS; MIM #610883), is reciprocal to the deletion on chromosome 17 that is responsible for Smith-Magenis syndrome [
         <a href="#rid64">
          64-66
         </a>
         ]. The common duplication spans 3.7 megabases (Mb), but the critical region spans 1.3 Mb and includes the retinoic acid receptor 1 (
         <em>
          RAI1
         </em>
         ) gene, a dose-sensitive gene presumably involved in the neurobehavioral and autism phenotype seen in these patients [
         <a href="#rid67">
          67
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16648.html" rel="external">
          "Microdeletion syndromes (chromosomes 12 to 22)", section on '17p11.2 deletion syndrome (Smith-Magenis syndrome)'
         </a>
         .)
        </p>
        <p>
         The clinical findings include infantile hypotonia, failure to thrive, intellectual disability, poor feeding, oropharyngeal dysplasia, and sleep apnea (obstructive and central sleep apnea with hypercarbia) [
         <a href="#rid64">
          64,65,68
         </a>
         ]. Speech development is significantly impaired, with delays, absent speech, delayed echolalia, and verbal apraxia. Autistic spectrum disorders are seen. Structural cardiovascular abnormalities (septal defects) are part of the spectrum and can be rather severe, including hypoplastic left heart [
         <a href="#rid66">
          66,69
         </a>
         ]. White matter abnormalities on brain magnetic resonance imaging (MRI) have been reported. In addition, electroencephalogram (EEG) tracings may show a common pattern with diffuse rhythmic activity during sleep [
         <a href="#rid70">
          70
         </a>
         ].
        </p>
        <p>
         Formal developmental and autism evaluations are recommended. Other screening studies include a brain MRI, echocardiogram, swallowing evaluations, and sleep studies. Referral to physical, occupational, and speech therapies is recommended.
        </p>
        <p class="headingAnchor" id="H2032143610">
         <span class="h1">
          17q12 DUPLICATION SYNDROME
         </span>
         <span class="headingEndMark">
          —
         </span>
         This duplication is reciprocal to the deletion encompassing the hepatic nuclear factor 1 (
         <em>
          HNF1
         </em>
         ) gene that causes cystic renal disease and maturity-onset diabetes of the young (MODY). Patients with these duplications have cognitive delays, speech delays, and behavioral problems [
         <a href="#rid71">
          71
         </a>
         ]. Seizures are seen in up 70 percent of patients, and autistic behaviors and stereotypical movements are also reported [
         <a href="#rid72">
          72
         </a>
         ]. Other developmental disorders in affected persons include schizophrenia and maladaptive behaviors. Additional findings include eye/vision problems in up to one-third of patients and cardiac and renal anomalies. Approximately 90 percent are inherited, while 10 percent are de novo [
         <a href="#rid73">
          73
         </a>
         ]. Additional findings in these patients include excessive growth, skeletal anomalies, dysmorphic features, and other endocrine abnormalities.
        </p>
        <p>
         Developmental evaluations are recommended, with appropriate therapies for identified problems. Endocrinology, cardiology, and neurology referrals may be indicated [
         <a href="#rid74">
          74
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H12818297">
         <span class="h1">
          17q21.31 DUPLICATION SYNDROME
         </span>
         <span class="headingEndMark">
          —
         </span>
         This duplication involves the microtubule-associated protein Tau (
         <em>
          MAPT
         </em>
         ) and corticotropin-releasing hormone receptor 1 (
         <em>
          CRHR1
         </em>
         ) genes (MIM #613533) and is similarly mediated by the inversion repeats flanking the
         <em>
          MAPT
         </em>
         gene as seen in the deletion. In the few reports of this duplication, it is associated with variable clinical features that range from normal cognition to severe intellectual disability, hypotonia, and joint laxity [
         <a href="#rid75">
          75
         </a>
         ]. Poor social interactions and behavioral abnormalities have been reported in patients with this duplication [
         <a href="#rid76">
          76
         </a>
         ]. A study in Alzheimer disease (AD) showed 4 patients out of 552 persons with early AD with duplications in this region [
         <a href="#rid77">
          77
         </a>
         ]. In addition, brain accumulation of the Tau-associated protein can clinically mimic AD [
         <a href="#rid78">
          78
         </a>
         ]. Further reports are required to determine the clinical range of this duplication. (See
         <a class="medical medical_review" href="/z/d/html/16648.html" rel="external">
          "Microdeletion syndromes (chromosomes 12 to 22)", section on '17q21.31 deletion syndrome'
         </a>
         .)
        </p>
        <p>
         Formal developmental and autism evaluations are recommended.
        </p>
        <p class="headingAnchor" id="H12818304">
         <span class="h1">
          22q11.2 DUPLICATION SYNDROME
         </span>
         <span class="headingEndMark">
          —
         </span>
         Duplications of the 22q11.2 region are reciprocal to the velocardiofacial syndrome (VCFS)/DiGeorge syndrome (DGS) recurrent deletions. The size of the duplications ranges from 1.5 to 3 megabases (Mb), depending upon the low copy repeats (LCRs) involved in the rearrangement. The LCRs surrounding the region are known as LCR22A to LCR22D. The common duplication is 3 Mb long and encompasses LCR22A to LCR22B. The common duplication includes T-box 1 (
         <em>
          TBX1
         </em>
         ), the putative gene for the congenital heart defects seen in this condition. (See
         <a class="medical medical_review" href="/z/d/html/16648.html" rel="external">
          "Microdeletion syndromes (chromosomes 12 to 22)", section on '22q11.2 deletion syndromes (DiGeorge syndrome/velocardiofacial syndrome)'
         </a>
         .)
        </p>
        <p>
         The clinical features share some similarities with VCFS/DGS, including mild-to-severe intellectual disability (deficits of memory performance, perceptual organization, and verbal comprehension; attention deficit hyperactivity disorder [ADHD]; and speech impairment), growth restriction, velopharyngeal incompetence, heart defects, and palatal abnormalities. Heart defects reported share similarities with the deletion and include defects affecting the outflow ventricular tracts and other conotruncal abnormalities [
         <a href="#rid79">
          79-81
         </a>
         ]. Other clinical findings reported include visual and hearing impairment, seizures, microcephaly, ptosis, and urogenital abnormalities. These duplications may also play a role in neuropsychiatric development, conferring protection against schizophrenia [
         <a href="#rid82">
          82
         </a>
         ]. Losses of these regions are highly associated with schizophrenia. Studies suggest that this duplication is more common (1 in 700) and has a higher incidence of congenital anomalies involving congenital heart defects, growth difficulties, and vision problems than previously reported [
         <a href="#rid83">
          83
         </a>
         ].
        </p>
        <p>
         Many of these duplications are inherited, some of them from unaffected parents; therefore, caution should be applied in interpreting genetic testing results and counseling families appropriately given the interfamilial and intrafamilial clinical variability seen with this duplication [
         <a href="#rid84">
          84,85
         </a>
         ].
        </p>
        <p>
         Screening studies include formal developmental evaluation, echocardiogram, and swallowing evaluations. Patients may benefit from physical, occupational, and speech therapies.
        </p>
        <p class="headingAnchor" id="H12818311">
         <span class="h1">
          22q13 DUPLICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Duplications of the 22q13 region have been reported in a few children with infantile hypotonia, mild-to-moderate developmental delay, microcephaly, autism spectrum disorder, growth deficiency, and mild dysmorphic facial features [
         <a href="#rid86">
          86
         </a>
         ]. This region includes several genes associated with mitochondrial function, and one patient with 22q13 duplication has been reported with mitochondrial disease [
         <a href="#rid87">
          87
         </a>
         ]. The critical region includes the Src homology 3 and multiple ankyrin repeat domains 3 (
         <em>
          SHANK3
         </em>
         ) gene. (See
         <a class="medical medical_review" href="/z/d/html/16648.html" rel="external">
          "Microdeletion syndromes (chromosomes 12 to 22)", section on '22q13.3 deletion syndrome (Phelan-McDermid syndrome)'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H10089610">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Genomic disorders
         </strong>
         – Genomic disorders are diseases that result from the loss or gain of chromosomal/DNA material. The most common and better delineated genomic disorders are divided in two main categories: those resulting from copy number losses (deletion syndromes) and those resulting from copy number gains (duplication syndromes). (See
         <a class="local">
          'Overview of genomic disorders'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Microduplications
         </strong>
         – Microduplications, or submicroscopic duplications, are chromosomal duplications that are too small to be detected by light microscopy using conventional cytogenetics methods. (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          7q11.23 duplication syndrome (Williams-Beuren region duplication syndrome)
         </strong>
         – Deletions in the 7q11.23 region are associated with Williams syndrome (MIM #609757). The reciprocal duplication causes a different clinical phenotype characterized by hypotonia and global developmental delay, with speech delay that can range from moderate to severe. (See
         <a class="local">
          '7q11.23 duplication syndrome (Williams-Beuren region duplication syndrome)'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          15a11-13 duplication syndrome
         </strong>
         – Gains and duplications of the 15q11-13 region are seen in some patients with autism (MIM #608636). These patients may also present with hypotonia, global developmental delay, attention deficit hyperactivity disorder (ADHD), ataxia, and seizures. (See
         <a class="local">
          '15q11-13 duplication syndrome'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          17p11.2 duplication syndrome (Charcot-Marie-Tooth type 1A [CMT1A] disease)
         </strong>
         – Recurrent 1.5 megabase (Mb) duplications in 17p11.2 involving the peripheral myelin protein 22 (
         <em>
          PMP22
         </em>
         ) gene are responsible for CMT1A disease (MIM #118220). CMT1A is a demyelinating motor-sensory neuropathy clinically characterized by progressive distal neuromuscular weakness. (See
         <a class="local">
          '17p11.2 duplication syndrome (Charcot-Marie-Tooth type 1A disease)'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          22q11.2 duplication syndrome (velocardiofacial syndrome/DiGeorge syndrome)
         </strong>
         – Duplications of the 22q11.2 region are reciprocal to the velocardiofacial syndrome (VCFS)/DiGeorge syndrome (DGS) recurrent deletions. The clinical features share some similarities with VCFS/DGS, including mild-to-severe intellectual disability (deficits of memory performance, perceptual organization, and verbal comprehension; ADHD; and speech impairment), growth restriction, velopharyngeal incompetence, heart defects, and palatal abnormalities. Other clinical findings reported include visual and hearing impairment, seizures, microcephaly, ptosis, and urogenital abnormalities. (See
         <a class="local">
          '22q11.2 duplication syndrome'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Brunetti-Pierri N, Berg JS, Scaglia F, et al. Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities. Nat Genet 2008; 40:1466.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mefford HC, Sharp AJ, Baker C, et al. Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N Engl J Med 2008; 359:1685.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dolcetti A, Silversides CK, Marshall CR, et al. 1q21.1 Microduplication expression in adults. Genet Med 2013; 15:282.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bernier R, Steinman KJ, Reilly B, et al. Clinical phenotype of the recurrent 1q21.1 copy-number variant. Genet Med 2016; 18:341.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Digilio MC, Bernardini L, Consoli F, et al. Congenital heart defects in recurrent reciprocal 1q21.1 deletion and duplication syndromes: rare association with pulmonary valve stenosis. Eur J Med Genet 2013; 56:144.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fiddes IT, Lodewijk GA, Mooring M, et al. Human-Specific NOTCH2NL Genes Affect Notch Signaling and Cortical Neurogenesis. Cell 2018; 173:1356.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kantaputra PN, Klopocki E, Hennig BP, et al. Mesomelic dysplasia Kantaputra type is associated with duplications of the HOXD locus on chromosome 2q. Eur J Hum Genet 2010; 18:1310.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cho TJ, Kim OH, Choi IH, et al. A dominant mesomelic dysplasia associated with a 1.0-Mb microduplication of HOXD gene cluster at 2q31.1. J Med Genet 2010; 47:638.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cukier HN, Lee JM, Ma D, et al. The expanding role of MBD genes in autism: identification of a MECP2 duplication and novel alterations in MBD5, MBD6, and SETDB1. Autism Res 2012; 5:385.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mullegama SV, Rosenfeld JA, Orellana C, et al. Reciprocal deletion and duplication at 2q23.1 indicates a role for MBD5 in autism spectrum disorder. Eur J Hum Genet 2014; 22:57.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mullegama SV, Elsea SH. Clinical and Molecular Aspects of MBD5-Associated Neurodevelopmental Disorder (MAND). Eur J Hum Genet 2016; 24:1376.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Streata I, Riza AL, Sosoi S, et al. Phenotype Heterogeneity in 3q29 Microduplication Syndrome. Curr Health Sci J 2020; 46:193.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ballif BC, Theisen A, Coppinger J, et al. Expanding the clinical phenotype of the 3q29 microdeletion syndrome and characterization of the reciprocal microduplication. Mol Cytogenet 2008; 1:8.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goobie S, Knijnenburg J, Fitzpatrick D, et al. Molecular and clinical characterization of de novo and familial cases with microduplication 3q29: guidelines for copy number variation case reporting. Cytogenet Genome Res 2008; 123:65.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lisi EC, Hamosh A, Doheny KF, et al. 3q29 interstitial microduplication: a new syndrome in a three-generation family. Am J Med Genet A 2008; 146A:601.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coyan AG, Dyer LM. 3q29 microduplication syndrome: Clinical and molecular description of eleven new cases. Eur J Med Genet 2020; 63:104083.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Quintero-Rivera F, Eno CC, Sutanto C, et al. 5q35 duplication presents with psychiatric and undergrowth phenotypes mediated by NSD1 overexpression and mTOR signaling downregulation. Hum Genet 2021; 140:681.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Franco LM, de Ravel T, Graham BH, et al. A syndrome of short stature, microcephaly and speech delay is associated with duplications reciprocal to the common Sotos syndrome deletion. Eur J Hum Genet 2010; 18:258.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang H, Lu X, Beasley J, et al. Reversed clinical phenotype due to a microduplication of Sotos syndrome region detected by array CGH: microcephaly, developmental delay and delayed bone age. Am J Med Genet A 2011; 155A:1374.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dikow N, Maas B, Gaspar H, et al. The phenotypic spectrum of duplication 5q35.2-q35.3 encompassing NSD1: is it really a reversed Sotos syndrome? Am J Med Genet A 2013; 161A:2158.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sanders SJ, Ercan-Sencicek AG, Hus V, et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 2011; 70:863.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berg JS, Brunetti-Pierri N, Peters SU, et al. Speech delay and autism spectrum behaviors are frequently associated with duplication of the 7q11.23 Williams-Beuren syndrome region. Genet Med 2007; 9:427.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klein-Tasman BP, Yund BD, Mervis CB. The Behavioral Phenotype of 7q11.23 Duplication Syndrome Includes Risk for Oppositional Behavior and Aggression. J Dev Behav Pediatr 2022; 43:e390.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mervis CB, Klein-Tasman BP, Huffman MJ, et al. Children with 7q11.23 duplication syndrome: psychological characteristics. Am J Med Genet A 2015; 167:1436.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Torniero C, Dalla Bernardina B, Novara F, et al. Dysmorphic features, simplified gyral pattern and 7q11.23 duplication reciprocal to the Williams-Beuren deletion. Eur J Hum Genet 2008; 16:880.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Earhart BA, Williams ME, Zamora I, et al. Phenotype of 7q11.23 duplication: A family clinical series. Am J Med Genet A 2017; 173:114.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morris CA, Mervis CB, Paciorkowski AP, et al. 7q11.23 Duplication syndrome: Physical characteristics and natural history. Am J Med Genet A 2015; 167A:2916.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zarate YA, Lepard T, Sellars E, et al. Cardiovascular and genitourinary anomalies in patients with duplications within the Williams syndrome critical region: phenotypic expansion and review of the literature. Am J Med Genet A 2014; 164A:1998.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baker P, Piven J, Schwartz S, Patil S. Brief report: duplication of chromosome 15q11-13 in two individuals with autistic disorder. J Autism Dev Disord 1994; 24:529.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bolton PF, Dennis NR, Browne CE, et al. The phenotypic manifestations of interstitial duplications of proximal 15q with special reference to the autistic spectrum disorders. Am J Med Genet 2001; 105:675.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Piard J, Philippe C, Marvier M, et al. Clinical and molecular characterization of a large family with an interstitial 15q11q13 duplication. Am J Med Genet A 2010; 152A:1933.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bundey S, Hardy C, Vickers S, et al. Duplication of the 15q11-13 region in a patient with autism, epilepsy and ataxia. Dev Med Child Neurol 1994; 36:736.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Flejter WL, Bennett-Baker PE, Ghaziuddin M, et al. Cytogenetic and molecular analysis of inv dup(15) chromosomes observed in two patients with autistic disorder and mental retardation. Am J Med Genet 1996; 61:182.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Bon BW, Mefford HC, Menten B, et al. Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome. J Med Genet 2009; 46:511.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Williams NM, Franke B, Mick E, et al. Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3. Am J Psychiatry 2012; 169:195.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhou D, Gochman P, Broadnax DD, et al. 15q13.3 duplication in two patients with childhood-onset schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2016; 171:777.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Budisteanu M, Papuc SM, Streata I, et al. The Phenotypic Spectrum of 15q13.3 Region Duplications: Report of 5 Patients. Genes (Basel) 2021; 12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stewart LR, Hall AL, Kang SH, et al. High frequency of known copy number abnormalities and maternal duplication 15q11-q13 in patients with combined schizophrenia and epilepsy. BMC Med Genet 2011; 12:154.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bacchelli E, Battaglia A, Cameli C, et al. Analysis of CHRNA7 rare variants in autism spectrum disorder susceptibility. Am J Med Genet A 2015; 167A:715.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           El-Hattab AW, Smolarek TA, Walker ME, et al. Redefined genomic architecture in 15q24 directed by patient deletion/duplication breakpoint mapping. Hum Genet 2009; 126:589.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kiholm Lund AB, Hove HD, Kirchhoff M. A 15q24 microduplication, reciprocal to the recently described 15q24 microdeletion, in a boy sharing clinical features with 15q24 microdeletion syndrome patients. Eur J Med Genet 2008; 51:520.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marangi G, Leuzzi V, Orteschi D, et al. Duplication of the Rubinstein-Taybi region on 16p13.3 is associated with a distinctive phenotype. Am J Med Genet A 2008; 146A:2313.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thienpont B, Béna F, Breckpot J, et al. Duplications of the critical Rubinstein-Taybi deletion region on chromosome 16p13.3 cause a novel recognisable syndrome. J Med Genet 2010; 47:155.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nagamani SC, Erez A, Bader P, et al. Phenotypic manifestations of copy number variation in chromosome 16p13.11. Eur J Hum Genet 2011; 19:280.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramalingam A, Zhou XG, Fiedler SD, et al. 16p13.11 duplication is a risk factor for a wide spectrum of neuropsychiatric disorders. J Hum Genet 2011; 56:541.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Allach El Khattabi L, Heide S, Caberg JH, et al. 16p13.11 microduplication in 45 new patients: refined clinical significance and genotype-phenotype correlations. J Med Genet 2020; 57:301.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fernandez BA, Roberts W, Chung B, et al. Phenotypic spectrum associated with de novo and inherited deletions and duplications at 16p11.2 in individuals ascertained for diagnosis of autism spectrum disorder. J Med Genet 2010; 47:195.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weiss LA, Shen Y, Korn JM, et al. Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 2008; 358:667.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kumar RA, Marshall CR, Badner JA, et al. Association and mutation analyses of 16p11.2 autism candidate genes. PLoS One 2009; 4:e4582.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kumar RA, KaraMohamed S, Sudi J, et al. Recurrent 16p11.2 microdeletions in autism. Hum Mol Genet 2008; 17:628.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Posar A, Visconti P. Neuro-Behavioral Phenotype in 16p11.2 Duplication: A Case Series. Children (Basel) 2020; 7.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCarthy SE, Makarov V, Kirov G, et al. Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet 2009; 41:1223.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Michaud JL, Lachance M, Hamdan FF, et al. The genetic landscape of infantile spasms. Hum Mol Genet 2014; 23:4846.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reinthaler EM, Lal D, Lebon S, et al. 16p11.2 600 kb Duplications confer risk for typical and atypical Rolandic epilepsy. Hum Mol Genet 2014; 23:6069.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steinman KJ, Spence SJ, Ramocki MB, et al. 16p11.2 deletion and duplication: Characterizing neurologic phenotypes in a large clinically ascertained cohort. Am J Med Genet A 2016; 170:2943.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schaaf CP, Goin-Kochel RP, Nowell KP, et al. Expanding the clinical spectrum of the 16p11.2 chromosomal rearrangements: three patients with syringomyelia. Eur J Hum Genet 2011; 19:152.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hippolyte L, Maillard AM, Rodriguez-Herreros B, et al. The Number of Genomic Copies at the 16p11.2 Locus Modulates Language, Verbal Memory, and Inhibition. Biol Psychiatry 2016; 80:129.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           D'Angelo D, Lebon S, Chen Q, et al. Defining the Effect of the 16p11.2 Duplication on Cognition, Behavior, and Medical Comorbidities. JAMA Psychiatry 2016; 73:20.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bruno DL, Anderlid BM, Lindstrand A, et al. Further molecular and clinical delineation of co-locating 17p13.3 microdeletions and microduplications that show distinctive phenotypes. J Med Genet 2010; 47:299.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Henry RK, Astbury C, Stratakis CA, Hickey SE. 17p13.3 microduplication including CRK leads to overgrowth and elevated growth factors: A case report. Eur J Med Genet 2016; 59:512.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klopocki E, Lohan S, Doelken SC, et al. Duplications of BHLHA9 are associated with ectrodactyly and tibia hemimelia inherited in non-Mendelian fashion. J Med Genet 2012; 49:119.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Curry CJ, Rosenfeld JA, Grant E, et al. The duplication 17p13.3 phenotype: analysis of 21 families delineates developmental, behavioral and brain abnormalities, and rare variant phenotypes. Am J Med Genet A 2013; 161A:1833.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bi W, Sapir T, Shchelochkov OA, et al. Increased LIS1 expression affects human and mouse brain development. Nat Genet 2009; 41:168.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Potocki L, Bi W, Treadwell-Deering D, et al. Characterization of Potocki-Lupski syndrome (dup(17)(p11.2p11.2)) and delineation of a dosage-sensitive critical interval that can convey an autism phenotype. Am J Hum Genet 2007; 80:633.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Potocki L, Chen KS, Park SS, et al. Molecular mechanism for duplication 17p11.2- the homologous recombination reciprocal of the Smith-Magenis microdeletion. Nat Genet 2000; 24:84.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yusupov R, Roberts AE, Lacro RV, et al. Potocki-Lupski syndrome: an inherited dup(17)(p11.2p11.2) with hypoplastic left heart. Am J Med Genet A 2011; 155A:367.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carmona-Mora P, Walz K. Retinoic Acid Induced 1, RAI1: A Dosage Sensitive Gene Related to Neurobehavioral Alterations Including Autistic Behavior. Curr Genomics 2010; 11:607.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Soler-Alfonso C, Motil KJ, Turk CL, et al. Potocki-Lupski syndrome: a microduplication syndrome associated with oropharyngeal dysphagia and failure to thrive. J Pediatr 2011; 158:655.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sanchez-Valle A, Pierpont ME, Potocki L. The severe end of the spectrum: Hypoplastic left heart in Potocki-Lupski syndrome. Am J Med Genet A 2011; 155A:363.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ciaccio C, Pantaleoni C, Milani D, et al. Neurological phenotype of Potocki-Lupski syndrome. Am J Med Genet A 2020; 182:2317.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nagamani SC, Erez A, Shen J, et al. Clinical spectrum associated with recurrent genomic rearrangements in chromosome 17q12. Eur J Hum Genet 2010; 18:278.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bierhals T, Maddukuri SB, Kutsche K, Girisha KM. Expanding the phenotype associated with 17q12 duplication: case report and review of the literature. Am J Med Genet A 2013; 161A:352.
          </a>
         </li>
         <li class="breakAll">
          Mefford H, Mitchell E, Hodge J. 17q12 recurrent duplication. In: GeneReviews [Internet], Adam MP, Ardinger HH, Pagon RA, et al (Eds), University of Washington, Seattle 2016.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mitchell E, Douglas A, Kjaegaard S, et al. Recurrent duplications of 17q12 associated with variable phenotypes. Am J Med Genet A 2015; 167A:3038.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kirchhoff M, Bisgaard AM, Duno M, et al. A 17q21.31 microduplication, reciprocal to the newly described 17q21.31 microdeletion, in a girl with severe psychomotor developmental delay and dysmorphic craniofacial features. Eur J Med Genet 2007; 50:256.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grisart B, Willatt L, Destrée A, et al. 17q21.31 microduplication patients are characterised by behavioural problems and poor social interaction. J Med Genet 2009; 46:524.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Le Guennec K, Quenez O, Nicolas G, et al. 17q21.31 duplication causes prominent tau-related dementia with increased MAPT expression. Mol Psychiatry 2017; 22:1119.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wallon D, Boluda S, Rovelet-Lecrux A, et al. Clinical and neuropathological diversity of tauopathy in MAPT duplication carriers. Acta Neuropathol 2021; 142:259.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ensenauer RE, Adeyinka A, Flynn HC, et al. Microduplication 22q11.2, an emerging syndrome: clinical, cytogenetic, and molecular analysis of thirteen patients. Am J Hum Genet 2003; 73:1027.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ou Z, Berg JS, Yonath H, et al. Microduplications of 22q11.2 are frequently inherited and are associated with variable phenotypes. Genet Med 2008; 10:267.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yobb TM, Somerville MJ, Willatt L, et al. Microduplication and triplication of 22q11.2: a highly variable syndrome. Am J Hum Genet 2005; 76:865.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rees E, Kirov G, Sanders A, et al. Evidence that duplications of 22q11.2 protect against schizophrenia. Mol Psychiatry 2014; 19:37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bartik LE, Hughes SS, Tracy M, et al. 22q11.2 duplications: Expanding the clinical presentation. Am J Med Genet A 2022; 188:779.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Courtens W, Schramme I, Laridon A. Microduplication 22q11.2: a benign polymorphism or a syndrome with a very large clinical variability and reduced penetrance?--Report of two families. Am J Med Genet A 2008; 146A:758.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wentzel C, Fernström M, Ohrner Y, et al. Clinical variability of the 22q11.2 duplication syndrome. Eur J Med Genet 2008; 51:501.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Okamoto N, Kubota T, Nakamura Y, et al. 22q13 Microduplication in two patients with common clinical manifestations: a recognizable syndrome? Am J Med Genet A 2007; 143A:2804.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Frye RE. Mitochondrial disease in 22q13 duplication syndrome. J Child Neurol 2012; 27:942.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 13557 Version 8.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19029900" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18784092" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23018752" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : 1q21.1 Microduplication expression in adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26066539" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Clinical phenotype of the recurrent 1q21.1 copy-number variant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23270675" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Congenital heart defects in recurrent reciprocal 1q21.1 deletion and duplication syndromes: rare association with pulmonary valve stenosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29856954" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Human-Specific NOTCH2NL Genes Affect Notch Signaling and Cortical Neurogenesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20648051" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Mesomelic dysplasia Kantaputra type is associated with duplications of the HOXD locus on chromosome 2q.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20577005" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : A dominant mesomelic dysplasia associated with a 1.0-Mb microduplication of HOXD gene cluster at 2q31.1.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23055267" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : The expanding role of MBD genes in autism: identification of a MECP2 duplication and novel alterations in MBD5, MBD6, and SETDB1.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23632792" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Reciprocal deletion and duplication at 2q23.1 indicates a role for MBD5 in autism spectrum disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27514998" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Clinical and Molecular Aspects of MBD5-Associated Neurodevelopmental Disorder (MAND).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32874693" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Phenotype Heterogeneity in 3q29 Microduplication Syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18471269" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Expanding the clinical phenotype of the 3q29 microdeletion syndrome and characterization of the reciprocal microduplication.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19287140" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Molecular and clinical characterization of de novo and familial cases with microduplication 3q29: guidelines for copy number variation case reporting.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18241066" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : 3q29 interstitial microduplication: a new syndrome in a three-generation family.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33039685" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : 3q29 microduplication syndrome: Clinical and molecular description of eleven new cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33389145" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : 5q35 duplication presents with psychiatric and undergrowth phenotypes mediated by NSD1 overexpression and mTOR signaling downregulation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19844260" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : A syndrome of short stature, microcephaly and speech delay is associated with duplications reciprocal to the common Sotos syndrome deletion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21567906" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Reversed clinical phenotype due to a microduplication of Sotos syndrome region detected by array CGH: microcephaly, developmental delay and delayed bone age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23913520" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : The phenotypic spectrum of duplication 5q35.2-q35.3 encompassing NSD1: is it really a reversed Sotos syndrome?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21658581" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17666889" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Speech delay and autism spectrum behaviors are frequently associated with duplication of the 7q11.23 Williams-Beuren syndrome region.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35580312" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : The Behavioral Phenotype of 7q11.23 Duplication Syndrome Includes Risk for Oppositional Behavior and Aggression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25900101" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Children with 7q11.23 duplication syndrome: psychological characteristics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18337728" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Dysmorphic features, simplified gyral pattern and 7q11.23 duplication reciprocal to the Williams-Beuren deletion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27615053" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Phenotype of 7q11.23 duplication: A family clinical series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26333794" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : 7q11.23 Duplication syndrome: Physical characteristics and natural history.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24844942" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Cardiovascular and genitourinary anomalies in patients with duplications within the Williams syndrome critical region: phenotypic expansion and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7961335" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Brief report: duplication of chromosome 15q11-13 in two individuals with autistic disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11803514" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : The phenotypic manifestations of interstitial duplications of proximal 15q with special reference to the autistic spectrum disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20635369" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Clinical and molecular characterization of a large family with an interstitial 15q11q13 duplication.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8050626" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Duplication of the 15q11-13 region in a patient with autism, epilepsy and ataxia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8669450" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Cytogenetic and molecular analysis of inv dup(15) chromosomes observed in two patients with autistic disorder and mental retardation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19372089" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22420048" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26968334" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : 15q13.3 duplication in two patients with childhood-onset schizophrenia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34356041" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : The Phenotypic Spectrum of 15q13.3 Region Duplications: Report of 5 Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22118685" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : High frequency of known copy number abnormalities and maternal duplication 15q11-q13 in patients with combined schizophrenia and epilepsy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25655306" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Analysis of CHRNA7 rare variants in autism spectrum disorder susceptibility.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19557438" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Redefined genomic architecture in 15q24 directed by patient deletion/duplication breakpoint mapping.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18755302" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : A 15q24 microduplication, reciprocal to the recently described 15q24 microdeletion, in a boy sharing clinical features with 15q24 microdeletion syndrome patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18688873" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Duplication of the Rubinstein-Taybi region on 16p13.3 is associated with a distinctive phenotype.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19833603" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Duplications of the critical Rubinstein-Taybi deletion region on chromosome 16p13.3 cause a novel recognisable syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21150890" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Phenotypic manifestations of copy number variation in chromosome 16p13.11.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21614007" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : 16p13.11 duplication is a risk factor for a wide spectrum of neuropsychiatric disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30287593" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : 16p13.11 microduplication in 45 new patients: refined clinical significance and genotype-phenotype correlations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19755429" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Phenotypic spectrum associated with de novo and inherited deletions and duplications at 16p11.2 in individuals ascertained for diagnosis of autism spectrum disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18184952" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Association between microdeletion and microduplication at 16p11.2 and autism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19242545" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Association and mutation analyses of 16p11.2 autism candidate genes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18156158" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Recurrent 16p11.2 microdeletions in autism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33086486" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Neuro-Behavioral Phenotype in 16p11.2 Duplication: A Case Series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19855392" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Microduplications of 16p11.2 are associated with schizophrenia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24781210" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : The genetic landscape of infantile spasms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24939913" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : 16p11.2 600 kb Duplications confer risk for typical and atypical Rolandic epilepsy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27410714" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : 16p11.2 deletion and duplication: Characterizing neurologic phenotypes in a large clinically ascertained cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20959866" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Expanding the clinical spectrum of the 16p11.2 chromosomal rearrangements: three patients with syringomyelia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26742926" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : The Number of Genomic Copies at the 16p11.2 Locus Modulates Language, Verbal Memory, and Inhibition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26629640" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Defining the Effect of the 16p11.2 Duplication on Cognition, Behavior, and Medical Comorbidities.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20452996" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Further molecular and clinical delineation of co-locating 17p13.3 microdeletions and microduplications that show distinctive phenotypes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27633569" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : 17p13.3 microduplication including CRK leads to overgrowth and elevated growth factors: A case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22147889" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Duplications of BHLHA9 are associated with ectrodactyly and tibia hemimelia inherited in non-Mendelian fashion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23813913" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : The duplication 17p13.3 phenotype: analysis of 21 families delineates developmental, behavioral and brain abnormalities, and rare variant phenotypes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19136950" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Increased LIS1 expression affects human and mouse brain development.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17357070" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Characterization of Potocki-Lupski syndrome (dup(17)(p11.2p11.2)) and delineation of a dosage-sensitive critical interval that can convey an autism phenotype.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10615134" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Molecular mechanism for duplication 17p11.2- the homologous recombination reciprocal of the Smith-Magenis microdeletion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21271656" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Potocki-Lupski syndrome: an inherited dup(17)(p11.2p11.2) with hypoplastic left heart.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21629438" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Retinoic Acid Induced 1, RAI1: A Dosage Sensitive Gene Related to Neurobehavioral Alterations Including Autistic Behavior.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21168152" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Potocki-Lupski syndrome: a microduplication syndrome associated with oropharyngeal dysphagia and failure to thrive.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21271655" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : The severe end of the spectrum: Hypoplastic left heart in Potocki-Lupski syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33043631" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Neurological phenotype of Potocki-Lupski syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19844256" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Clinical spectrum associated with recurrent genomic rearrangements in chromosome 17q12.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23307502" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Expanding the phenotype associated with 17q12 duplication: case report and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23307502" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Expanding the phenotype associated with 17q12 duplication: case report and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26420380" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Recurrent duplications of 17q12 associated with variable phenotypes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17576104" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : A 17q21.31 microduplication, reciprocal to the newly described 17q21.31 microdeletion, in a girl with severe psychomotor developmental delay and dysmorphic craniofacial features.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19502243" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : 17q21.31 microduplication patients are characterised by behavioural problems and poor social interaction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27956742" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : 17q21.31 duplication causes prominent tau-related dementia with increased MAPT expression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34095977" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Clinical and neuropathological diversity of tauopathy in MAPT duplication carriers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14526392" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Microduplication 22q11.2, an emerging syndrome: clinical, cytogenetic, and molecular analysis of thirteen patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18414210" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Microduplications of 22q11.2 are frequently inherited and are associated with variable phenotypes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15800846" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Microduplication and triplication of 22q11.2: a highly variable syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24217254" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Evidence that duplications of 22q11.2 protect against schizophrenia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34845825" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : 22q11.2 duplications: Expanding the clinical presentation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18260141" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Microduplication 22q11.2: a benign polymorphism or a syndrome with a very large clinical variability and reduced penetrance?--Report of two families.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18707033" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Clinical variability of the 22q11.2 duplication syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17975801" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : 22q13 Microduplication in two patients with common clinical manifestations: a recognizable syndrome?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22378673" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Mitochondrial disease in 22q13 duplication syndrome.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
